Determination of diphenylpyraline in plasma and urine by high-performance liquid chromatography.
A rapid, reliable and specific reversed-phase high-performance liquid chromatographic procedure is described for the determination of diphenylpyraline hydrochloride at nanogram concentrations in plasma and urine. After extraction of the drug with n-pentane-2-propanol (50:1) from alkalinized samples, the organic extract was evaporated to dryness, reconstituted with methanol and chromatographed using a 5-micron Asahipak ODP-50 C18 column with UV detection at 254 nm. The elution time for diphenylpyraline was 7.9 min. The overall recovery of diphenylpyraline from spiked plasma and urine samples at concentrations ranging from 53 to 740 ng/ml were 94.65% and 92.29%, respectively. Linearity and precision data for plasma and urine standards after extraction were acceptable. The limit of detection was 15 ng/ml for both plasma and urine samples at 0.002 AUFS.
Ebete
K O
KO
Laboratory of Pharmaceutical Analysis, School of Pharmacy, Aristotelian University, Thessaloniki, Greece.
Koundourellis
J E
JE
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006634:Histamine H1 Antagonists / Q000097:blood / Q000378:metabolism* / Q000652:urine; D006801:Humans; D010880:Piperidines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012680:Sensitivity and Specificity; D013056:Spectrophotometry, Ultraviolet
D006634:Histamine H1 Antagonists; D010880:Piperidines; C009871:diphenylpyraline